Soleno Therapeutics, the pharmaceutical company behind the newly FDA-approved hyperphagia treatment, VYKAT XR, is conducting a groundbreaking ‘Burden of Illness Study.’ This study aims to… Read More »Soleno’s Study to show the Impact of PWS on Patients, Caregivers and the Healthcare System
On Wednesday, 14th May, we are delighted to announce that The Rt Hon. the Lord Naseby PC will be hosting an awareness-raising event for policymakers… Read More »PWS Stronger Together and The House of Lords!!
The FDA has approved DCCR (Diazoxide Choline Controlled-Release) for the treatment of hyperphagia in individuals with Prader-Willi Syndrome (PWS)! This approval is a huge leap… Read More »BREAKING NEWS! 🥳
Would you like a Blue Peter Badge? Do you know someone aged 5-15 years old that would like to earn a Blue Peter Badge? Do… Read More »Blue Peter!
The use of weight loss drugs is a fascinating area in the field of obesity management, particularly for individuals with Prader-Willi Syndrome (PWS). Some individuals… Read More »Weight Loss Drugs and PWS
The Benefact Group’s Movement for Good is an annual program by The Benefact Group that aims to give back to charities and good causes by… Read More »The Movement for Good